News Focus
News Focus
icon url

stockforce

03/29/19 1:16 AM

#115156 RE: stockforce #115155

PharmCo has two lines of CBD products on their shelf right now for sale:

Ananda Professional
https://anandaprofessional.com

Pharma Canna
https://www.pharmacanna.us

with these lines we'll be able to work with these manufacturers to create our own formulas and our own herbal based on natural non-GMO blend for CBD that we can maximize the health benefits.

https://seekingalpha.com/article/4251682-progressive-care-inc-rxmd-ceo-shital-mars-q4-2018-annual-report-business-update-results?part=single
icon url

Lomond

03/29/19 2:27 AM

#115157 RE: stockforce #115155

AMAZING RXMD! Thanks STOCKFORCE!
icon url

Jimmy Quick

03/29/19 8:39 AM

#115165 RE: stockforce #115155

Thanks, saved me the time of having to do that. ProgressiveCare is making a lot of great moves and decisions here in 2019. A good focus that they understand, is on improving reimbursement in many of the business lines.
icon url

Jimmy Quick

04/03/19 3:11 PM

#115538 RE: stockforce #115155

5. We're looking at by the end of the year having an S-1 prepared to be - prepared to be filed with the SEC. We would like to do it much faster and as we work on this we will provide all of our shareholders with updates as to where we stand in the process. If we can get the books in the proper presentation form for the SEC and we can get that a clean audit done in 45 days instead of 90 that all speeds up the timeline on this.

But I want to give a reasonable estimate of when this can - when shareholders can look for and I want to say the end of the year for looking out for an S-1. And that brings us to the SEC.

Once we're with the SEC, now we'll file - now we're fully reporting company that changes completely where we stand, now we’re at our OTCQX, instead of QB we're no longer alternative filers and a whole new group of investors and institutions can look at us and see what we have to offer and we can look at different capital structures for any future financing, any future acquisition, any future capital needs for our growth through the SEC network instead of the alternative reporting network, which has presented its own challenges.